Fosun Pharma

Fosun Pharma USA Inc. was established in 2017 as a subsidiary of Fosun Pharma (SSE: 600196) (SEHK: 2196) and Fosun International Limited (SEHK: 656), a leading enterprise group and investment company. Innovation, R&D, superior quality, supply reliability, and patient affordability are the core drivers of Fosun Pharma USA Inc.Fosun Pharma USA Inc. provides specialty injectables, develops partnerships to introduce late-stage assets to the Chinese and overseas markets, and seeks investment opportunities leveraging cutting-edge medical technologies through our drug discovery incubator, FUSION. The company embodies an entrepreneurial spirit, committed to improving the lives of patients and their families through innovative, convenient, and affordable healthcare.